Product
itraconazole
Aliases
Sporanox
Name
SPORANOX
INN Name
itraconazole
FDA Approved
Yes
5 clinical trials
1 organization
5 indications
1 document
Indication
HealthyIndication
CancerIndication
Solid TumorIndication
Breast NeoplasmsIndication
MetastasisClinical trial
A First-in-Human, Phase I, Double-blind, Placebo-controlled, Single and Multiple Ascending Oral Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KRP-A218 in Healthy Subjects, Including Food-Effect and Drug-drug Interaction With ItraconazoleStatus: Completed, Estimated PCD: 2022-04-21
Clinical trial
An Open-label Fixed Sequence Trial to Investigate the Potential Drug-drug Interaction of Intravenous Volasertib Co-administered With a P-gp and CYP3A4 Inhibitor (Itraconazole p.o.) in Patients With Various Solid TumoursStatus: Completed, Estimated PCD: 2014-05-30
Clinical trial
A Phase 1, Open-label, Parallel-group, Fixed-sequence Study to Investigate the Effect of the CYP3A Inducer Rifampin and the CYP3A Inhibitor Itraconazole on the Pharmacokinetics of Pamiparib (BGB-290) in Cancer PatientsStatus: Completed, Estimated PCD: 2019-10-25
Clinical trial
Effect of Itraconazole on the Pharmacokinetics of a Single Oral Dose of BI 1584862 in Healthy Male Subjects (an Open-label, Two-period, Fixed-sequence Design Study)Status: Completed, Estimated PCD: 2023-11-10
Clinical trial
A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast CancerStatus: Completed, Estimated PCD: 2012-02-01
Document
DailyMed Label: SPORANOXOrganization
Janssen Pharmaceuticals, Inc.